Provided by Tiger Fintech (Singapore) Pte. Ltd.

Armata Pharmaceuticals, Inc.

1.23
+0.05004.24%
Post-market: 1.230.00000.00%16:05 EDT
Volume:7.03K
Turnover:8.68K
Market Cap:44.51M
PE:-1.38
High:1.25
Open:1.25
Low:1.20
Close:1.18
Loading ...
Mar 17, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2022

Major Issues Report

8-K - Current report
Feb 11, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 05, 2022

Major Issues Report

8-K - Current report
Nov 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
May 18, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 14, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 05, 2021

Major Issues Report

8-K - Current report
Apr 05, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 18, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 17, 2021

Major Issues Report

8-K - Current report
Feb 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 27, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 27, 2021

Major Issues Report

8-K - Current report
Jan 06, 2021

Major Issues Report

8-K - Current report
Dec 09, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans